– USA, FL – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the appointments of Dr. Brian Bernick and Mark Glickman as Interim Co-CEOs and Co-Principal Executive Officers, succeeding Hugh O’Dowd as CEO.
Before this appointment, co-founder Dr. Bernick served as CSMO and Mr. Glickman served as CBO.
The Company also announced the appointment of The Honorable Tommy Thompson, who served as the Chairman of the Board since 2012, as the Executive Chairman.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. TherapeuticsMD’s products are designed to address the unique changes and challenges women experience throughout their lives with a therapeutic focus on family planning, reproductive health, and menopause management. TherapeuticsMD is committed to advancing women’s health and championing awareness of their healthcare issues.
For more information: https://www.therapeuticsmd.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
